T1	Participants 13 81	recurrent or persistent nasopharyngeal carcinomas after radiotherapy
T2	Participants 491 531	residual nasopharyngeal carcinomas (NPC)
T3	Participants 669 971	Thirty six NPC patients underwent head and neck CT, Tc-MIBI SPECT, and FDG-PET four months after radiotherapy to differentiate recurrent or residual NPC from benign lesions. Histopathologic examinations of nasopharyngeal biopsies were performed for all 36 patients. No patients had multiple foci of NPC
